HSP90 for Imaging Malignanices (Solid Tumors) - Clinical Trial
What is the Purpose of this Study?
If you choose to join this study, you will:
- Be given the study drug, HS-196 by injection up to 36 hours before surgery
- Allow us to use your tissue that is removed for research
- Give blood on the day of the injection, day after injection, 1 week following injection, and 1 month following injection
Breast, Prostate, and Pancreatic Cancer Imaging
Who Can Participate in the Study?
Adults who are having surgery for:
- Prostate cancer
- pancreatic cancer
- breast cancer
What is Involved?
We are doing this study to see if the study drug, HS-196, is safe and to see if there are any side effects that people may experience while taking it.
HS-196 is a drug which marks cancer cells and it may help doctors see the cancer during and after surgery.